KP TISSUE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.55 CAD | -0.93% |
|
0.00% | -5.21% |
| Jun. 11 | Transcript : KP Tissue Inc. - Shareholder/Analyst Call | |
| May. 31 | Kruger Products Unionized Employees on Strike At Crabtree Plant and Joliette Warehouse | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.57 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -5.21% | 62.27M | D | ||
| +13.56% | 46.46B | B- | ||
| +1.55% | 18.55B | A- | ||
| +3.08% | 3.61B | - | B- | |
| +12.59% | 2.86B | - | C- | |
| +57.52% | 1.41B | - | ||
| -30.20% | 1.23B | - | C- | |
| +3.64% | 842M | - | ||
| +7.82% | 713M | B | ||
| +32.78% | 461M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- KPT Stock
- Ratings KP Tissue Inc.
